ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

Deciphering the redox chemistry of physical plasma-treated clinically-relevant liquids as novel therapy against ovarian cancer

Implementing Organization

Principal Investigator
Dr. Naresh Kumar
Ramalingaswami fellow
|
National Institute Of Pharmaceutical Education And Research (Niper-G)
CO-Principal Investigator
Dr. BidyaDhar Sahu
National Institute Of Pharmaceutical Education And Research (Niper-G)

Project Overview

This project aims to identify the optimal tumor-toxic target chemistry of plasma-treated liquids (PTL) as anticancer agents. The project will use clinically-relevant liquids and experimental methods to optimize plasma redox chemistry. The PTLs will be tested in vitro for efficacy in treating metastatic ovarian cancer, a common cancer in young women. The molecular basis of anticancer PTL redox effects will be investigated, and the best plasma condition will be investigated for pre-clinical impact. The novel redox-active PTL approach will be tested in mice.

Related Research

View All
Funding Organization
Funding Organization

—

Quick Information
Area of Research
Pharmaceutical Sciences
Focus Area
Pharmacology, Toxicology
Start Year
2021
Sanction Amount
₹ 51.15 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop